Clinico-pathological characteristics of prostate cancer in Korean men and nomograms for the prediction of the pathological stage of the clinically localized prostate cancer: A multi-institutional update

Korean Journal of Urology

Volumn 48, Issue 2, 2007, Pages 125-130

  Song, Cheryn ^a   Kang, Taejin ^a   Lee, Moo Song ^a   Ro, Jae Y ^a   Lee, Sang Eun ^b   Lee, Eunsik ^b   Choi, Han Yong ^c   Han, Deok Hyun ^c   Hong, Sung Joon ^d   Chung, Byung Ha ^d   Kim, Choung Soo ^a   Ahn, Hanjong ^a  

^a University of Ulsan   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Nomograms; Prostate neoplasm; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PREOPERATIVE EVALUATION; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; SEMINAL VESICLE; SOUTH KOREA; TUMOR DIFFERENTIATION;

EID: 34247855976     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2007.48.2.125     Document Type: Article

References (18)

1. Cancer Registration and Biostatistics Branch, National Cancer Center. Cancer Statistics in Korea, 2003
2. Song C, Kim JB, Chung H, Kim CS, Ro JY, Ahn H. Nomograms for the prediction of the pathological stage of the clinically localized prostate cancer in Korean men. Korean J Urol 2003;44:753-8
3. Song C, Kang T, Ro JY, Lee MS, Kim CS, Ahn H. Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 2005;20: 262-6
4. Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005;103:538-45
5. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Longterm biochemical disease-free and cancer-specific survival following anatomic, radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28: 555-65
6. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528-34
7. Freedland SJ, Mangold LA, Walsh PC, Partin AW. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol 2005;174:1276-81
8. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445-51
9. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001;58:843-8
10. Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, et al. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0ng/ml. J Urol 2006;176:554-8
11. Derweesh IH, Kupelian PA, Zippe C, Levin HS, Brainard J, Magi-Galluzzi C, et al. Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 2004;22:300-6
12. Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys 2006;65:999-1007
13. Steuber T, Graefen M, Haese A, Erbersdobler A, Chun FK, Schlom T, et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006;175:939-44
14. Ozgur A, Onol FF, Turkeri LN. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy. Int Urol Nephrol 2004;36:369-73
15. Secin FP, Bianco FJ Jr, Vickers AJ, Reuter V, Wheeler T, Fearn PA, et al. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy. Cancer 2006;106:2369-75
16. Johnson CW, Anastasiadis AG, McKiernan JM, Salomon L, Eaton S, Goluboff ET, et al. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Urol Oncol 2004;22:107-11
17. Ramsden AR, Chodak G. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup. BJU Int 2004;93:961-4
18. McAleer SJ, Schultz D, Whittington R, Malkowicz SB, Renshaw A, Wein A, et al. PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level. Urol Oncol 2005;23:311-7